miRecule

mirecule.com

mi Recule™ is a biotechnology company focused on developing RNA therapies for cancer and muscular dystrophy. Utilizing its proprietary DREAmi R™ platform, the company leverages genomic patient data to create tailored therapeutics aimed at addressing the genetic abnormalities causing these diseases. With lead programs in Head & Neck Cancer and Facioscapulohumeral Muscular Dystrophy, mi Recule is positioned to deliver first-in-class therapies. The company has gained traction through strategic collaborations, including partnerships with Sanofi, and has recently been awarded a patent for its innovative RNA therapeutics.